Claritin Rebate Settlement Leaves Door Open For Boston Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Schering-Plough's July 30 settlement with the Philadelphia U.S. Attorney does not preclude additional criminal prosecution of the company over its Medicaid "best price" reporting for Claritin